中外製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/12/19 | 7,180 | 7,180 | 7,060 | 7,100 | -40 | -0.6% | 715,100 |
2018/12/18 | 7,200 | 7,230 | 7,080 | 7,140 | -140 | -1.9% | 827,800 |
2018/12/17 | 7,330 | 7,370 | 7,260 | 7,280 | +40 | +0.6% | 735,900 |
2018/12/14 | 7,330 | 7,370 | 7,190 | 7,240 | -100 | -1.4% | 1,713,600 |
2018/12/13 | 7,360 | 7,400 | 7,290 | 7,340 | ±0 | ±0% | 836,700 |
2018/12/12 | 7,260 | 7,410 | 7,260 | 7,340 | +170 | +2.4% | 1,109,900 |
2018/12/11 | 7,200 | 7,260 | 7,150 | 7,170 | -30 | -0.4% | 809,400 |
2018/12/10 | 7,150 | 7,220 | 7,140 | 7,200 | -100 | -1.4% | 751,500 |
2018/12/07 | 7,300 | 7,370 | 7,230 | 7,300 | +50 | +0.7% | 817,400 |
2018/12/06 | 7,300 | 7,360 | 7,170 | 7,250 | -150 | -2% | 1,073,700 |
2018/12/05 | 7,440 | 7,450 | 7,330 | 7,400 | -110 | -1.5% | 972,100 |
2018/12/04 | 7,640 | 7,650 | 7,490 | 7,510 | -110 | -1.4% | 1,041,100 |
2018/12/03 | 7,810 | 7,850 | 7,580 | 7,620 | -150 | -1.9% | 1,244,900 |
2018/11/30 | 7,700 | 7,780 | 7,590 | 7,770 | +160 | +2.1% | 1,528,100 |
2018/11/29 | 7,520 | 7,700 | 7,500 | 7,610 | +130 | +1.7% | 763,700 |
2018/11/28 | 7,260 | 7,560 | 7,240 | 7,480 | +250 | +3.5% | 1,187,700 |
2018/11/27 | 7,270 | 7,280 | 7,160 | 7,230 | +20 | +0.3% | 652,800 |
2018/11/26 | 7,250 | 7,300 | 7,120 | 7,210 | -50 | -0.7% | 832,300 |
2018/11/22 | 7,120 | 7,300 | 7,120 | 7,260 | +170 | +2.4% | 752,900 |
2018/11/21 | 7,000 | 7,120 | 6,970 | 7,090 | -40 | -0.6% | 794,400 |
2018/11/20 | 7,150 | 7,190 | 7,100 | 7,130 | -20 | -0.3% | 586,000 |
2018/11/19 | 7,090 | 7,190 | 7,080 | 7,150 | +70 | +1% | 605,700 |
2018/11/16 | 7,000 | 7,150 | 6,960 | 7,080 | +180 | +2.6% | 817,700 |
2018/11/15 | 6,790 | 6,940 | 6,780 | 6,900 | +20 | +0.3% | 454,000 |
2018/11/14 | 6,940 | 6,990 | 6,840 | 6,880 | +10 | +0.1% | 661,100 |
2018/11/13 | 6,840 | 6,880 | 6,730 | 6,870 | -20 | -0.3% | 777,100 |
2018/11/12 | 6,850 | 6,950 | 6,800 | 6,890 | +30 | +0.4% | 434,000 |
2018/11/09 | 7,010 | 7,050 | 6,830 | 6,860 | -110 | -1.6% | 925,300 |
2018/11/08 | 6,920 | 7,020 | 6,900 | 6,970 | +200 | +3% | 679,000 |
2018/11/07 | 6,780 | 6,850 | 6,730 | 6,770 | -30 | -0.4% | 728,700 |
2018/11/06 | 6,760 | 6,850 | 6,720 | 6,800 | +120 | +1.8% | 634,100 |
2018/11/05 | 6,620 | 6,700 | 6,560 | 6,680 | +70 | +1.1% | 811,100 |
2018/11/02 | 6,430 | 6,660 | 6,410 | 6,610 | +250 | +3.9% | 1,368,900 |
2018/11/01 | 6,570 | 6,600 | 6,340 | 6,360 | -270 | -4.1% | 1,176,300 |
2018/10/31 | 6,500 | 6,640 | 6,470 | 6,630 | +70 | +1.1% | 810,200 |
2018/10/30 | 6,610 | 6,670 | 6,540 | 6,560 | -20 | -0.3% | 905,900 |
2018/10/29 | 6,660 | 6,700 | 6,580 | 6,580 | +10 | +0.2% | 554,100 |
2018/10/26 | 6,620 | 6,700 | 6,500 | 6,570 | +50 | +0.8% | 1,079,200 |
2018/10/25 | 6,540 | 6,620 | 6,410 | 6,520 | -150 | -2.2% | 1,274,600 |
2018/10/24 | 6,760 | 6,780 | 6,640 | 6,670 | -10 | -0.1% | 807,600 |
2018/10/23 | 6,740 | 6,800 | 6,670 | 6,680 | -150 | -2.2% | 912,200 |
2018/10/22 | 6,830 | 6,880 | 6,750 | 6,830 | +30 | +0.4% | 472,600 |
2018/10/19 | 6,640 | 6,820 | 6,640 | 6,800 | -10 | -0.1% | 643,700 |
2018/10/18 | 6,810 | 6,840 | 6,790 | 6,810 | +20 | +0.3% | 591,900 |
2018/10/17 | 6,810 | 6,860 | 6,760 | 6,790 | -10 | -0.1% | 930,700 |
2018/10/16 | 6,720 | 6,830 | 6,700 | 6,800 | +140 | +2.1% | 1,331,900 |
2018/10/15 | 6,670 | 6,760 | 6,620 | 6,660 | -80 | -1.2% | 1,003,500 |
2018/10/12 | 6,700 | 6,770 | 6,610 | 6,740 | -60 | -0.9% | 1,624,700 |
2018/10/11 | 6,780 | 6,860 | 6,700 | 6,800 | -130 | -1.9% | 1,653,100 |
2018/10/10 | 6,910 | 6,970 | 6,820 | 6,930 | ±0 | ±0% | 1,087,400 |
1551~
1600
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「中外薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
中外薬 | 862,000円 | +1.7% | +5.0% | 2.90% | 34.60倍 | 7.46倍 |
|
ロシュ傘下で成長続ける異色の医薬品大手。抗体・バイオで先行、抗がん剤、骨・関節領域に強い |
第一三共 | 370,200円 | +6.0% | +4.0% | 2.11% | 22.98倍 | 4.25倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
武 田 | 441,900円 | +7.7% | +206.9% | 4.44% | 59.10倍 | 1.00倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
大塚HD | 769,700円 | +2.2% | +10.2% | 1.56% | 14.78倍 | 1.49倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
アステラス薬 | 145,800円 | +0.9% | +380.2% | 5.35% | 20.08倍 | 1.72倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
市場注目の銘柄
チャート関連のコラム